Self-Reported Nonadherence Predicts Changes of Medication after Discharge from Hospital in People with Parkinson’s Disease

Table 1

Clinical and demographic characteristics of the patients (n = 125).

Characteristic	Value
	N	%
Gender
Female	49	39.2
Male	76	60.8
Marital status
Single	5	4.0
Married	99	79.2
Divorced/widowed	19	15.2
No data	2	1.6
Education
Low	29	22.8
Middle	49	38.6
High	45	35.4
No data	4	3.1
Occupation
Unemployed	2	1.6
Pensioned	114	91.2
Employed	9	7.2
	Mean	SD
Age (yr)	70.0	8.0
H&Y stage (median, IQR)	3.0	1.0
MDS-UPDRS III	24.3	11.2
LEDD (mg)	602.2	346.7
Disease duration (yr)	8.1	5.2
NMSQ	10.6	4.9
MoCA	23.5	2.9
BDI-II	12.5	8.8
SAMS total	6.4	6.7

H&Y, Hoehn and Yahr stage; MDS-UPDRS III, Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale for motor function; LEDD, levodopa equivalent daily dose; NMSQ, nonmotor symptoms questionnaire; MoCA, Montreal Cognitive Assessment sum score; BDI-II, Beck Depression Inventory II; SAMS, Stendal Adherence to Medication Score.